Table 4.

Average costs, life-years, and QALYs per patient with and without tranexamic acid for the treatment of post-partum haemorrhage as well as base case ICERs in each country

	Cost (US$)	Life-years	QALYs	ICER	Cost-effectiveness threshold range*
Nigeria
Tranexamic acid	127·18	22·13	20·58	··	··
No tranexamic acid	90·06	21·94	20·40	··	··
Difference	37·12	0·19	0·18	$208 per QALY	$446–$2880 per QALY
Pakistan
Tranexamic acid	118·03	24·59	22·86	··	··
No tranexamic acid	111·48	24·50	22·78	··	··
Difference	6·55	0·09	0·08	$83 per QALY	$314–$2416 per QALY

QALY=quality-adjusted life-year. ICER=incremental cost-effectiveness ratio.

^*Values were adjusted for purchasing power parity.²⁰